Articles Vol. 67 No. 8 28/08/2026

ANALYSIS OF PSYCHO-SOCIAL FACTORS IN GENERAL ANXIETY DISORDER IN PATIENTS WITH PSORIASIS.

Vu Hoang The1, Ngoc Tran Nguyen1, Doanh Le Huu2, Vinh Nguyen Thi Ha2
1 Department of Psychiatry – Hanoi Medical University
2 Department of Dermatology – Hanoi Medical University
DOI: 10.52163/yhc.v67i8.6314
134 Views
0 Downloads
Abstract

Research objective: To analyze certain psychosocial factors associated with generalized anxiety disorder (GAD) in patients with psoriasis.
Subjects and methods: A cross-sectional descriptive study was conducted on 236 patients diagnosed with psoriasis vulgaris who were examined and treated at the National Hospital of Dermatology and Venereology during 2025–2026.
Results: Being single was associated with GAD (OR = 2.88; 95% CI: 1.02–8.10; p = 0.049), and perceived stigma was associated with GAD (OR = 6.49; 95% CI: 2.99–14.05; p < 0.001). No statistically significant associations were found regarding age, age of psoriasis onset, or disease duration.
Conclusion: GAD is an issue requiring attention in patients with psoriasis. Perceived stigma is a factor associated with GAD, suggesting a need to integrate the screening and detection of GAD symptoms, the assessment of stigma experiences, and the provision of psychosocial support and supportive resources into the management of psoriasis patients.

Keywords
generalized anxiety disorder, psoriasis
References
[1]
Global report on psoriasis. Accessed May 5, 2026. https://www.who.int/publications/i/item/9789241565189 Google Scholar
[2]
Jalenques I, Bourlot F, Martinez E, et al. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysi. Acta Derm Venereol. 2022;102:adv00769. doi:10.2340/actadv.v102.1386 Google Scholar
[3]
Anxiety disorders. Accessed May 11, 2026. https://www.who.int/news-room/fact-sheets/detail/anxiety-disorders Google Scholar
[4]
Jalenques I, Bourlot F, Martinez E, et al. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysi. Acta Derm Venereol. 2022;102:adv00769. doi:10.2340/actadv.v102.1386 Google Scholar
[5]
Jalenques I, Bourlot F, Martinez E, et al. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysi. Acta Derm Venereol. 2022;102:adv00769. doi:10.2340/actadv.v102.1386 Google Scholar
[6]
Blackstone B. Assessing and Improving Psychological Well-Being in Psoriasis: Considerations for the Clinician. Psoriasis Auckl NZ. 2022;12. doi:10.2147/PTT.S328447 Google Scholar
[7]
Jalenques I, Bourlot F, Martinez E, et al. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysi. Acta Derm Venereol. 2022;102:adv00769. doi:10.2340/actadv.v102.1386 Google Scholar
[8]
Zhang H, Yang Z, Tang K, Sun Q, Jin H. Stigmatization in Patients With Psoriasis: A Mini Review. Front Immunol. 2021;12:715839. doi:10.3389/fimmu.2021.715839 Google Scholar
[9]
Jankowiak B, Kowalewska B, Krajewska-Kułak E, Khvorik DF. Stigmatization and Quality of Life in Patients with Psoriasis. Dermatol Ther. 2020;10(2):285-296. doi:10.1007/s13555-020-00363-1 Google Scholar
[10]
Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L, Słomian A. Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2018;35(1):60-66. doi:10.5114/pdia.2016.62287 Google Scholar
[11]
Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35(12):1747-1759. doi:10.1017/S0033291705006069 Google Scholar